Revance Therapeutics, Inc.

DEUTSCHE BANK AG\

Report date

12/31/2024

Quarter

2024 Q4

Filed

6/30/2025

Shares

89,736

Value ($000)

273

Weight

0.0%

2014 Q1 - 2024 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q4	6/30/2025	273	0.0%	89,736	12/31/2024
2024 Q3	6/26/2025	325	0.0%	62,694	9/30/2024
2024 Q2	6/12/2025	95	0.0%	37,061	6/30/2024
2024 Q1	6/2/2025	224	0.0%	45,429	3/31/2024
2023 Q4	2/14/2024	389	0.0%	44,302	12/31/2023
2023 Q3	11/24/2023	517	0.0%	45,042	9/30/2023
2023 Q2	8/14/2023	1,008	0.0%	39,842	6/30/2023
2023 Q1	5/15/2023	1,853	0.0%	57,518	3/31/2023
2022 Q4	2/13/2023	2,923	0.0%	158,319	12/31/2022
2022 Q3	11/14/2022	873	0.0%	32,337	9/30/2022
2022 Q2	8/11/2022	566	0.0%	40,953	6/30/2022
2022 Q1	5/13/2022	892	0.0%	45,762	3/31/2022
2021 Q4	2/16/2022	827	0.0%	50,660	12/31/2021
2021 Q3	11/4/2021	1,334	0.0%	47,896	9/30/2021
2021 Q2	8/11/2021	1,858	0.0%	62,687	6/30/2021
2021 Q1	5/13/2021	3,897	0.0%	139,453	3/31/2021
2020 Q4	2/16/2021	1,424	0.0%	50,275	12/31/2020
2020 Q3	11/12/2020	949	0.0%	37,758	9/30/2020
2020 Q2	8/13/2020	3,285	0.0%	134,567	6/30/2020
2020 Q1	5/14/2020	2,602	0.0%	175,862	3/31/2020
2019 Q4	2/14/2020	2,526	0.0%	155,712	12/31/2019
2018 Q3	12/21/2021	5,804	—	233,563	9/30/2018
2018 Q2	4/21/2020	8,167	—	297,520	6/30/2018
2014 Q1	5/15/2014	55	0.0%	1,750	3/31/2014